176 related articles for article (PubMed ID: 18706774)
1. Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.
Martins SS; Storr CL; Zhu H; Chilcoat HD
Drug Alcohol Depend; 2009 Jan; 99(1-3):58-67. PubMed ID: 18706774
[TBL] [Abstract][Full Text] [Related]
2. Profile of dependence symptoms among extramedical opioid analgesic users.
Martins SS; Ghandour LA; Chilcoat HD
Addict Behav; 2007 Oct; 32(10):2003-19. PubMed ID: 17270358
[TBL] [Abstract][Full Text] [Related]
3. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004.
Cicero TJ; Inciardi JA; Muñoz A
J Pain; 2005 Oct; 6(10):662-72. PubMed ID: 16202959
[TBL] [Abstract][Full Text] [Related]
4. Trends in the Nonmedical Use of OxyContin, United States, 2006 to 2013.
Jones CM; Muhuri PK; Lurie PG
Clin J Pain; 2017 May; 33(5):452-461. PubMed ID: 27513641
[TBL] [Abstract][Full Text] [Related]
5. Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder.
Cassidy TA; Thorley E; Black RA; DeVeaugh-Geiss A; Butler SF; Coplan P
J Opioid Manag; 2017; 13(6):425-440. PubMed ID: 29308589
[TBL] [Abstract][Full Text] [Related]
6. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
Cicero TJ; Ellis MS
JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
[TBL] [Abstract][Full Text] [Related]
7. Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach.
Ghandour LA; Martins SS; Chilcoat HD
Int J Methods Psychiatr Res; 2008; 17(2):89-103. PubMed ID: 18393262
[TBL] [Abstract][Full Text] [Related]
8. Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population.
Dowling K; Storr CL; Chilcoat HD
Clin J Pain; 2006; 22(9):776-83. PubMed ID: 17057559
[TBL] [Abstract][Full Text] [Related]
9. Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties.
Cheng HG; Coplan PM
Postgrad Med; 2018 Aug; 130(6):568-574. PubMed ID: 29978755
[TBL] [Abstract][Full Text] [Related]
10. Toward primary prevention of extra-medical OxyContin® use among young people.
Deandrea DC; Troost JP; Anthony JC
Prev Med; 2013 Sep; 57(3):244-6. PubMed ID: 23701847
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
[TBL] [Abstract][Full Text] [Related]
12. Non-medical use of OxyContin Tablets in the United States.
Sees KL; Di Marino ME; Ruediger NK; Sweeney CT; Shiffman S
J Pain Palliat Care Pharmacother; 2005; 19(2):13-23. PubMed ID: 16061457
[TBL] [Abstract][Full Text] [Related]
13. Impact of abuse-deterrent OxyContin on prescription opioid utilization.
Hwang CS; Chang HY; Alexander GC
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):197-204. PubMed ID: 25393216
[TBL] [Abstract][Full Text] [Related]
14. Illicit use of opioids: is OxyContin a "gateway drug"?
Grau LE; Dasgupta N; Harvey AP; Irwin K; Givens A; Kinzly ML; Heimer R
Am J Addict; 2007; 16(3):166-73. PubMed ID: 17612819
[TBL] [Abstract][Full Text] [Related]
15. Internet-based survey of nonmedical prescription opioid use in the United States.
Katz N; Fernandez K; Chang A; Benoit C; Butler SF
Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
[TBL] [Abstract][Full Text] [Related]
16. Prescription OxyContin abuse among patients entering addiction treatment.
Carise D; Dugosh KL; McLellan AT; Camilleri A; Woody GE; Lynch KG
Am J Psychiatry; 2007 Nov; 164(11):1750-6. PubMed ID: 17974941
[TBL] [Abstract][Full Text] [Related]
17. Discordant reporting of nonmedical opioid use in a nationally representative sample of US high school seniors.
Palamar JJ; Shearston JA; Cleland CM
Am J Drug Alcohol Abuse; 2016 Sep; 42(5):530-538. PubMed ID: 27315427
[TBL] [Abstract][Full Text] [Related]
18. Comparing rates and characteristics of ambulance attendances related to extramedical use of pharmaceutical opioids in Victoria, Australia from 2013 to 2018.
Nielsen S; Crossin R; Middleton M; Lam T; Wilson J; Scott D; Martin C; Smith K; Lubman D
Addiction; 2020 Jun; 115(6):1075-1087. PubMed ID: 31742765
[TBL] [Abstract][Full Text] [Related]
19. Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.
Severtson SG; Ellis MS; Kurtz SP; Rosenblum A; Cicero TJ; Parrino MW; Gilbert MK; Buttram ME; Dasgupta N; BucherBartelson B; Green JL; Dart RC
Drug Alcohol Depend; 2016 Nov; 168():219-229. PubMed ID: 27716575
[TBL] [Abstract][Full Text] [Related]
20. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users.
Jonas AB; Young AM; Oser CB; Leukefeld CG; Havens JR
Soc Sci Med; 2012 May; 74(10):1602-9. PubMed ID: 22465379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
